Non-Hodgkin’s lymphoma (NHL) begins in the lymphatic system, part of the body’s immune system. Non-Hodgkin’s lymphoma is slightly more common in men than in women, and more than 90 percent of newly diagnosed NHL cases occur in adults. Because there is lymphatic tissue throughout the body, adult NHL can begin in almost any part of the body. Childhood NHL and its treatment are often different from adult NHL.
At The James, we have a team of physicians and physician-researchers who specialize in diagnosing and treating non-Hodgkin’s lymphoma. With research and treatment areas under one roof, we are better able to translate research advances to patient care – so our team of specialists can provide the best possible care for patients with non-Hodgkin’s lymphoma.
Researcher-physicians at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute have more than 20 clinical trials under way involving non-Hodgkin’s lymphoma patients, and a group of scientists led by OSUCCC Director Michael Caligiuri, MD, has received a $9.5 million grant from the National Cancer Institute to study ways to boost the human immune system’s innate capacity for fighting cancer.
This section of the Web site will give you access to:
If you have questions about non-Hodgkin's lymphoma, please call The James Line – a free cancer information resource and physician referral service – at 614-293-5066 or 1-800-293-5066 (outside Franklin County) or e-mail now. The James Line oncology nurses can
be reached Monday-Friday 8:00 a.m.-5:00 p.m. (except weekends and